Sandesh Mahatme's Net Worth
$49.2 Million
Who is Sandesh Mahatme?
Sandesh Mahatme has an estimated net worth of $49.2 Million. This is based on reported shares across multiple companies, which include Flexion Therapeutics Inc, Sarepta Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Stalar 4, Inc., Stalar 3 Inc., and CRISPR Therapeutics AG.
SEC CIK
Sandesh Mahatme's CIK is 0001511034
Past Insider Trading and Trends
2019 was Sandesh Mahatme's most active year for acquiring shares with 26 total transactions. Sandesh Mahatme's most active month to acquire stocks was the month of May. 2019 was Sandesh Mahatme's most active year for disposing of shares, totalling 31 transactions. Sandesh Mahatme's most active month to dispose stocks was the month of July. 2019 saw Sandesh Mahatme paying a total of $9,424,882.48 for 466,789 shares, this is the most they've acquired in one year. In 2019 Sandesh Mahatme cashed out on 745,599 shares for a total of $40,092,905.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Flexion Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.5K |
—
|
—
| 4.5K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92
EVP, CFO & CBO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -45.06% | -16.62K |
$19.69 | $74,941.02 | 20.26K |
May 11 - Jul 8
| |||
Form 4
| +22.20% | 6.7K |
—
|
—
| 36.88K |
Feb 28
| |||
Form 4
|
—
|
0
|
$77.19 | -$12,077,056.65 | 30.18K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
$62.68 | -$3,447,697.50 | 30.18K |
Aug 21 - Aug 22
| |||
Form 4
| +47.76% | 9.75K |
$24.73 | $241,232.04 | 30.18K |
Aug 15
| |||
Form 4
| +22.09% | 3.7K |
$118.68 | -$350,462.04 | 20.43K |
Mar 28
| |||
Form 4
| +332.50% | 12.86K |
$73.97 | $323.92 | 16.73K |
Mar 19
| |||
Form 4
| -55.28% | -4.78K |
—
|
—
| 3.87K |
Feb 28 - Mar 4
| |||
Form 4
|
—
|
0
|
$84.43 | -$7,874,750.00 | 8.65K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
$75.16 | -$7,159,613.14 | 8.65K |
Scheduled
|
Jan 30 - Jan 31
| ||
Form 4
| -46.73% | -18.12K |
$71.31 | -$12,404,727.18 | 20.66K |
Scheduled
|
Oct 24
| ||
Form 4
| -17.98% | -8.50K |
$121.02 | -$1,028,791.02 | 38.78K |
Aug 8
| |||
Form 4
| +10.84% | 4.63K |
$89.22 | -$180,581.28 | 47.29K |
May 22
| |||
Form 4
| +4.32% | 1.77K |
$52.54 | $9.52 | 42.66K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +20.77% | 7.03K |
$37.88 | -$237,280.32 | 40.9K |
Aug 3
| |||
Form 4
| +4.64% | 1.5K |
$28.32 | -$1,245,117.60 | 33.86K |
Scheduled
|
Jul 20 - Jul 21
| ||
Form 4
| -0.53% | -171.00 |
$30.30 | -$5,181.30 | 32.36K |
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +3.17% | 1K |
$23.85 | $23,850.00 | 32.53K |
Nov 9
| |||
Form 4
|
—
|
0
|
$31.99 | -$1,085,502.00 | 31.53K |
Scheduled
|
Oct 17
| ||
Form 4
| +343.99% | 24.43K |
—
|
—
| 31.53K |
Sep 19
| |||
Form 4
| -12.48% | -1.01K |
$26.07 | -$26,408.91 | 7.1K |
Aug 31
| |||
Form 4
| +62.30% | 3.12K |
—
|
—
| 8.12K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
∞
| 5K |
$31.10 | $155,500.00 | 5K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Stalar 4, Inc. No price found
Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Stalar 3 Inc. No price found
Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||